Talk:Pharmaceutical marketing

From Wikipedia, the free encyclopedia

This is the talk page for discussing improvements to the Pharmaceutical marketing article.

Contents

[edit] Comment

This article seems like a statement of personal point of view against pharmaceutical industry advertising. There is no presentation of an opposing viewpoint. Maybe this should be removed or revised to include statements of fact from both sides of the argument.NanaLana 00:34, 16 Mar 2005 (UTC)

SO FIX IT. It's a wiki. JFW | T@lk 18:47, 9 Jun 2005 (UTC)

What about the benefits of pharmaceutical marketing? By providing peer reviewed documentation in the form of studies to doctors, the doctors are able to have accurate and timely information. Marketing also allows drug companies to provide samples to patients and in many cases free medication. Pharmaceutical marketing is not just advertising on television like this article portrays.

That's right. Away with the witchhunt. Imagine a world without pharmaceutical companies willing to take tremendous risks to develop new and better medication. JFW | T@lk 18:47, 9 Jun 2005 (UTC)

[edit] organized and expanded a little

I organized and expanded the treatment a little. The text for a number of headings is a little sparse. I intend to start filling in this text over the next few days. CommodiCast 22:32, 12 October 2005 (UTC)

Great work, though the table of contents is now a bit over large. - SimonP 22:47, 12 October 2005 (UTC)
Thanks for the help. I will try to do something with the table of contents CommodiCast 19:17, 16 October 2005 (UTC)

[edit] Cleanup

This article received a cleanup tag from SecretLondon. I am somewhat new to wikipedia, so I did not know exactly what cleanup he was specifically referring to. He did not leave a message. I cleaned some things up anyway and will continue to do so. I removed the cleanup tag.CommodiCast 23:19, 20 October 2005 (UTC)

[edit] Citing sources

The major weakness of this article, as it stands now, is that it needs to do a much better job of citing sources. I haven't tagged every assertion with "citation needed", cause that would just be obnoxious, but we should probably work on referencing some of the assertions. I started with some minor grammar/style edits, but let's work on sourcing the comments since otherwise the article is a good start. MastCell 19:23, 21 August 2006 (UTC)

[edit] Peer influence

I am concerned about this edit which added the sentence: "Some pharmaceutical companies identify influential colleagues through commercially available prescription writing and patient level data (see list of data providers in this article)." The "see list of data providers in this article" appears out of context. Was this copied from somewhere? -AED 23:58, 18 September 2006 (UTC)

[edit] Removal of information

I removed the following sections from the article. They appear to be lecture notes rather than encyclopedic prose. I'm not clear on what is trying to be said, so I am unable to rewrite. I would ask that citations be provided if the information is rewritten and reincluded. -AED 00:04, 19 September 2006 (UTC)

[edit] Sales force optimization

Design sales territories in a manner that evenly spreads the work load across territories, districts, and regions. Minimize the amount of time a sales representative spends driving and maximize the time the representative has to meet with physicians.

[edit] Call planning

Design the optimal timing for each individual physician sales call. Forecast each physician's prescribing response to a sales call over the next few weeks. Minimize the "annoyance factor."

[edit] Sales force effectiveness

Monitor the performance of the sales force in the target universe of physicians. Adjust market message, reach, frequency, timing, territories, or other actions in order to increase sales.

These are details of different activities relating to tuning the sales organization. I saw the reference to Epocrates and did not think it was cool to link externally like that? I would propose that it gets deleted. Epocrates just republishes the PDR with links to a system of that reports the formulary status for the Palm. --Chrispounds 02:55, 26 September 2006 (UTC)